Antituberculosis therapy-induced liver injury: A case report and clinical management strategies
Drug-Induced Liver Injury (DILI) from Anti-Tuberculosis Therapy (ATT) is increasingly common and affects patient outcomes. Factors like alcohol use, existing liver conditions, and gender (especially females) influence DILI risk. Recognizing and managing DILI quickly is crucial
Authors
- Sara Shreen
Publication Details
- Journal
- Journal of Clinical Images and Medical Case Reports
- Published
- 2024-08-08
- DOI
- https://doi.org/10.52768/2766-7820/3199
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00